114 related articles for article (PubMed ID: 9440547)
1. Induction of autocytotoxic T cells with cyclosporine and interferon-gamma for patients with non-Hodgkin's lymphoma after transplantation of peripheral blood stem cells.
Nakao S; Miura Y; Zeng W; Takami A; Sugimori N; Yamazaki H; Yachie A; Shiobara S; Matsuda T
J Allergy Clin Immunol; 1997 Dec; 100(6 Pt 2):S65-9. PubMed ID: 9440547
[TBL] [Abstract][Full Text] [Related]
2. Induction of autologous graft-versus-host disease with cyclosporin A after peripheral blood stem cell transplantation: analysis of factors affecting induction.
Miura Y; Ueda M; Zeng W; Wang H; Takami A; Yamazaki H; Kawamura Y; Shiobara S; Nakao S
J Allergy Clin Immunol; 2000 Jul; 106(1 Pt 2):S51-7. PubMed ID: 10887334
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of cyclosporin A-induced autologous graft-versus-host disease after peripheral blood stem cell transplantation by utilizing selected CD34(+) cells.
Miura Y; Ueda M; Takami A; Shiobara S; Nakao S; Hess AD
Bone Marrow Transplant; 2003 Oct; 32(8):785-90. PubMed ID: 14520422
[TBL] [Abstract][Full Text] [Related]
4. Induction of autologous graft-versus-host disease: results of a randomized prospective clinical trial in patients with poor risk lymphoma.
Bolaños-Meade J; Garrett-Mayer E; Luznik L; Anders V; Webb J; Fuchs EJ; Huff CA; Matsui W; Borrello IM; Brodsky R; Kasamon YL; Swinnen LJ; Flinn IW; Ambinder RF; Jones RJ; Hess AD; Vogelsang GB
Biol Blood Marrow Transplant; 2007 Oct; 13(10):1185-91. PubMed ID: 17889355
[TBL] [Abstract][Full Text] [Related]
5. Cytolytic effector mechanisms and gene expression in autologous graft-versus-host disease: distinct roles of perforin and Fas ligand.
Miura Y; Thoburn CJ; Bright EC; Hess AD
Biol Blood Marrow Transplant; 2004 Mar; 10(3):156-70. PubMed ID: 14993881
[TBL] [Abstract][Full Text] [Related]
6. Autografting followed by nonmyeloablative immunosuppressive chemotherapy and allogeneic peripheral-blood hematopoietic stem-cell transplantation as treatment of resistant Hodgkin's disease and non-Hodgkin's lymphoma.
Carella AM; Cavaliere M; Lerma E; Ferrara R; Tedeschi L; Romanelli A; Vinci M; Pinotti G; Lambelet P; Loni C; Verdiani S; De Stefano F; Valbonesi M; Corsetti MT
J Clin Oncol; 2000 Dec; 18(23):3918-24. PubMed ID: 11099321
[TBL] [Abstract][Full Text] [Related]
7. Strong increase in the percentage of the CD8bright+ CD28- T-cells and delayed engraftment associated with cyclosporine-induced autologous GVHD.
Garin L; Rigal D; Souillet G; Bernaud J; Mérieux Y; Philippe N
Eur J Haematol; 1996 Mar; 56(3):119-23. PubMed ID: 8598229
[TBL] [Abstract][Full Text] [Related]
8. High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cells.
Nademanee A; Sniecinski I; Schmidt GM; Dagis AC; O'Donnell MR; Snyder DS; Parker PM; Stein AS; Smith EP; Molina A
J Clin Oncol; 1994 Oct; 12(10):2176-86. PubMed ID: 7523609
[TBL] [Abstract][Full Text] [Related]
9. Erythroderma after autologous bone marrow transplantation modified by administration of cyclosporine and interferon gamma for breast cancer.
Horn TD; Altomonte V; Vogelsang G; Kennedy MJ
J Am Acad Dermatol; 1996 Mar; 34(3):413-7. PubMed ID: 8609251
[TBL] [Abstract][Full Text] [Related]
10. Autologous graft-versus-host disease induction in advanced breast cancer: role of peripheral blood progenitor cells.
van der Wall E; Horn T; Bright E; Passos-Coehlo JL; Bond S; Clarke B; Altomonte V; McIntyre K; Vogelsang G; Noga SJ; Davis JM; Thomassen J; Ohly KV; Lee SM; Fetting J; Armstrong DK; Davidson NE; Hess AD; Kennedy MJ
Br J Cancer; 2000 Dec; 83(11):1405-11. PubMed ID: 11076645
[TBL] [Abstract][Full Text] [Related]
11. Immune modulation in autologous bone marrow transplantation: cyclosporine and gamma-interferon trial.
Vogelsang G; Bitton R; Piantadosi S; Altomonte V; Horn T; Jones R; Miller C; Marcellus D; Abrams R; Hess A
Bone Marrow Transplant; 1999 Sep; 24(6):637-40. PubMed ID: 10490729
[TBL] [Abstract][Full Text] [Related]
12. Assessment and characterization of the cytolytic T lymphocyte response against Epstein-Barr virus in patients with non-Hodgkin's lymphoma after autologous peripheral blood stem cell transplantation.
Nolte A; Buhmann R; Straka C; Emmerich B; Hallek M
Bone Marrow Transplant; 1998 May; 21(9):909-16. PubMed ID: 9613783
[TBL] [Abstract][Full Text] [Related]
13. The treatment of relapsed or refractory intermediate grade non-Hodgkin's lymphoma with autologous bone marrow transplantation followed by cyclosporine and interferon.
Gryn J; Johnson E; Goldman N; Devereux L; Grana G; Hageboutros A; Fernandez E; Constantinou C; Harrer W; Viner E; Goldberg J
Bone Marrow Transplant; 1997 Feb; 19(3):221-6. PubMed ID: 9028549
[TBL] [Abstract][Full Text] [Related]
14. Cytokine-primed bone marrow stem cells vs. peripheral blood stem cells for autologous transplantation: a randomized comparison of GM-CSF vs. G-CSF.
Weisdorf D; Miller J; Verfaillie C; Burns L; Wagner J; Blazar B; Davies S; Miller W; Hannan P; Steinbuch M; Ramsay N; McGlave P
Biol Blood Marrow Transplant; 1997 Oct; 3(4):217-23. PubMed ID: 9360784
[TBL] [Abstract][Full Text] [Related]
15. Infusions of interleukin-1 alpha after autologous transplantation for Hodgkin's disease and non-Hodgkin's lymphoma induce effector cells with antilymphoma cytolytic activity.
Katsanis E; Weisdorf DJ; Xu Z; Dancisak BB; Halet ML; Blazar BR
J Clin Immunol; 1994 May; 14(3):205-11. PubMed ID: 7929695
[TBL] [Abstract][Full Text] [Related]
16. Reconstitution of the cellular immune response after autologous peripheral blood stem cell transplantation in patients with non-Hodgkin's lymphoma.
Nolte A; Buhmann R; Emmerich B; Schendel D; Hallek M
Br J Haematol; 2000 Feb; 108(2):415-23. PubMed ID: 10691875
[TBL] [Abstract][Full Text] [Related]
17. Induction of autologous graft-versus-host disease after autologous peripheral blood stem cell transplantation.
Nakamura H; Nakao T; Ujiie H; Karasuno T; Teshima H; Komatsu K; Ishiguro S; Hiraoka A; Masaoka T
J Allergy Clin Immunol; 1999 May; 103(5 Pt 2):S457-61. PubMed ID: 10329849
[TBL] [Abstract][Full Text] [Related]
18. Optimal timing for the collection and in vitro expansion of cytotoxic CD56(+) lymphocytes from patients undergoing autologous peripheral blood stem cell transplantation.
Clausen J; Petzer AL; Vergeiner B; Enk M; Stauder R; Gastl G; Gunsilius E
J Hematother Stem Cell Res; 2001 Aug; 10(4):513-21. PubMed ID: 11522234
[TBL] [Abstract][Full Text] [Related]
19. Systemic aspergillosis in a patient with non-Hodgkin's lymphoma developing acute graft-versus-host disease after autologous peripheral blood stem cell transplantation.
Messina G; Quartarone E; Console G; Cuzzola M; Iacopino O; Martino M; Irrera G; Morabito F; Iacopino P
Haematologica; 2002 Jul; 87(7):ECR22. PubMed ID: 12091138
[TBL] [Abstract][Full Text] [Related]
20. Cyclosporine-induced autologous graft-versus-host disease following autologous blood stem cell transplantation for lymphoma.
Pati AR; Godder KT; Abhyankar SH; Gee AP; Henslee-Downey PJ
Bone Marrow Transplant; 1996 Jun; 17(6):1081-3. PubMed ID: 8807118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
